SAN DIEGO, California — A review of prescription patterns reveals calcitonin gene-related peptide (CGRP) and gepant medications for migraine reveals significant gender and racial disparities that may affect access to...

Although survival rates for patients with multiple myeloma are improving, with a 5-year rate of about 60%, many patients relapse after treatment. "Patients have seen impressive advances in survival because...

As temperatures and humidity soar outside, what's happening inside the human body can become a life-or-death battle decided by just a few degrees. The critical danger point outdoors for illness...

11 hours agoBy Aurelia Foster, Health reporter, BBC NewsJoseph KjorstadDylan Kjorstad, 14, has had chemotherapy twice a month to shrink the tumour, ahead of planned surgery this monthA 14-year-old boy with cancer...

Robin Alderman faces an agonizing reality: Gene therapy might cure her son Camden's rare, inherited immune deficiency. But it's not available to him. In 2022, London-based Orchard Therapeutics stopped investing...

The European Commission (EC) has granted marketing authorization for Altuvoct (efanesoctocog alfa, Sobi) to treat and prevent bleeds and for perioperative prophylaxis in hemophilia A for all age groups and...

Gabuzda is a fourth-year medical student. As a medical student, every time I meet a physician for the first time, I will inevitably be asked about my specialty of interest....

Truqap (capivasertib, AstraZeneca) in combination with Faslodex (fulvestrant) has been approved by the European Commission for the treatment of adult patients with: estrogen receptor (ER)-positive,human epidermal growth factor receptor 2 (HER2)‑negative,locally...

Jeremy Faust is editor-in-chief of MedPage Today, an emergency medicine physician at Brigham and Women's Hospital in Boston, and a public health researcher. He is author of the Substack column...

According to a phase III study presented at the recent American Society of Clinical Oncology (ASCO) meeting, subcutaneous amivantamab (Rybrevant) was noninferior to intravenous amivantamab for pretreated advanced EGFR-mutated non-small...

The FDA has warned birth tissue company Neobiosis that its products derived from human amniotic fluid and umbilical cord are unapproved drugs. In its warning letter to CEO Ian White,...

The FDA expanded the approval of delandistrogene moxeparvovec-rokl (Elevidys) gene therapy for Duchenne muscular dystrophy on Thursday to include ambulatory or non-ambulatory patients ages 4 years and older with a...

SAN DIEGO — ChatGPT, an artificial intelligence (AI) tool that can provide headache information, makes significant errors regarding migraine drug treatments but does better when it comes to nonpharmacologic therapies,...

CHICAGO — Prominent Chinese oncologist Tony Shu-Kam Mok, MD, who presented as first author of a phase 3 non–small cell lung cancer study at ASCO 2024, made a dramatic swerve...

Note that some links may require registration or subscription. Actor Donald Sutherland, who starred as surgeon Hawkeye Pierce in the film "M*A*S*H" among numerous other roles, died at age 88...

Glofitamab, a fixed-duration CD20xCD3 bispecific antibody, combined with a chemotherapy regimen of gemcitabine and oxaliplatin (GemOx), shows significant survival benefits in the treatment of patients with relapsed/refractory diffuse large B-cell...

In this exclusive MedPage Today video, Roy Herbst, MD, PhD, of Yale Cancer Center in New Haven, Connecticut, discusses exciting new data surrounding osimertinib (Tagrisso) in patients with EGFR-mutated non-small...

MADRID — The chemotherapy-free combination of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) that is standard in treating low-risk acute promyelocytic leukemia (APL) also shows superior benefits in the...

TOPLINE:For patients with early multinodular hepatocellular carcinoma (HCC) who are ineligible for liver transplant, liver resection provides a survival advantage over percutaneous radiofrequency ablation and transarterial chemoembolization (TACE).METHODOLOGY:The presentation of...

In the wake of a debilitating cyberattack against one of the nation's largest health care systems, Marvin Ruckle, a nurse at an Ascension hospital in Wichita, Kansas, said he had...